ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1861

CD8T Cells Depletion Promotes Human Tph/Tfh Cells Proliferation and Sjogren Syndrome Like Symptoms Without Graft versus Host Diseases in PBMC Transferred-humanized Mice

Yuzo Koda1, Piruzyan Mariam1, Sota Fujimori1, Ryota Sato2 and Sayuka Kato1, 1Mitsubishi Tanabe Pharma Corporation, Yokohama, Kanagawa, Japan, 2Mitsubishi Tanabe Pharma Corporation, Brighton, MA

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Sjögren's syndrome, T Cell, T-Lymphocyte

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Peripheral helper T (Tph) and follicular helper T (Tfh) cells are known to play a central role in the interaction between T and B cells, as well as in the mechanism of antibody production, indicating their potential importance in autoimmune diseases. Additionally, there have been reports demonstrating that Tph cells can directly cause tissue damage through the production of cytotoxic factors. However, our understanding of the physiology of Tph/Tfh cells, crucial for developing therapeutic drugs for autoimmune diseases, remains limited. The properties and differentiation mechanisms of Tph/Tfh cells differ between humans and mice, posing challenges for investigating their physiological roles, especially in vivo. To address this, it is essential to establish a method for replicating human Tph/Tfh cells in mice. In this study, we unexpectedly observed a significant proliferation of human Tph/Tfh and B cells in the spleens of immuno-deficient mice after transferring CD8T cells-depleted PBMCs. This led us to explore the potential use of these cells as a tool for studying human Tph/Tfh cells in mice and as a model for autoimmune disease.

Methods: We created humanized mice by transferring human peripheral blood mononuclear cells (PBMC; 1×107 cells/mouse, hPBMC mice) or CD8T cells-depleted human PBMC (1×107 cells/mouse, CD8T⊿hPBMC mice) to immune-deficient (NSG) mice. We compared the effects of graft versus host disease (GVHD) between hPBMC mice and CD8T⊿hPBMC mice. Additionally, we used flow cytometry to examine the immunological phenotype of CD8T⊿hPBMC mice.

Results: GVHD resulting from the transfer of PBMC to immune-deficient mice was significantly reduced in CD8T⊿PBMC mice, which could be used without GVHD symptoms for at least 30 days. Subsequently, we observed a notable increase in a Tph-like subset (CD4+PD-1+CXCR5- cells), a Tfh-like subset (CD4+PD-1+CXCR5- cells), and B cells in the spleens of CD8T⊿PBMC mice compared to hPBMC mice. These Tph and Tfh-like subsets of CD8T⊿PBMC mice expressed IL-21/CXCL13, functional molecules of these cells. We also investigated the presence of CXCL13+Tph cells in systemic organs of CD8T⊿PBMC mice and found that these cells infiltrated organs exhibiting symptoms similar to those of Sjogren’s syndrome (SjS), such as salivary glands (SGs), lungs, and kidneys. Our analysis of single-cell RNA sequencing of human immune cells infiltrating the SGs revealed a significant infiltration of CXCL13+IL-21+Tph cells, accompanied by a marked decrease in saliva volume as observed in SjS. These findings suggest that these cells may induce Sjogren’s-like symptoms through damage to the SGs. Finally, we examined the effects of administering IL-12/TGF-β1/IFN-α, known to induce Tph/Tfh cells, on salivary gland symptoms in CD8T⊿PBMC mice. This resulted in the activation of Tph cells and exacerbation of symptoms in the SGs, indicating the potential importance of Tph cell activation in the pathogenesis of this model.

Conclusion: This study demonstrated that PBMC-derived human Tph/Tfh and B cells can proliferate in vivo without GVHD symptoms by transferring CD8T cells-depleted human PBMC, leading to the development of SjS-like pathology.


Disclosures: Y. Koda: Mitsubishi Tanabe Pharma Corporation, 3; P. Mariam: Mitsubishi Tanabe Pharma Corporation, 3; S. Fujimori: Mitsubishi Tanabe Pharma Corporation, 3; R. Sato: Mitsubishi Tanabe Pharma Corporation, 3; S. Kato: Mitsubishi Tanabe Pharma Corporation, 3.

To cite this abstract in AMA style:

Koda Y, Mariam P, Fujimori S, Sato R, Kato S. CD8T Cells Depletion Promotes Human Tph/Tfh Cells Proliferation and Sjogren Syndrome Like Symptoms Without Graft versus Host Diseases in PBMC Transferred-humanized Mice [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/cd8t-cells-depletion-promotes-human-tph-tfh-cells-proliferation-and-sjogren-syndrome-like-symptoms-without-graft-versus-host-diseases-in-pbmc-transferred-humanized-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd8t-cells-depletion-promotes-human-tph-tfh-cells-proliferation-and-sjogren-syndrome-like-symptoms-without-graft-versus-host-diseases-in-pbmc-transferred-humanized-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology